This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

endometrial cancer

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Endometrial carcinoma is the most common gynaecological cancer in the developed world.

  • carcinoma of the endometrium is responsible for around 92% of the cancers of the uterine corpus (the remainder being uterine carcinosarcomas and sarcomas)
  • it is predominantly a disease of post-menopausal women which makes up around 90% of all women diagnosed as having endometrial carcinoma
    • mean age at diagnosis is around 63 years

Endometrial carcinoma can be divided histopathologically into 2 major types:

  • type 1 cancers
    • account for 80-90% of endometrial carcinomas
    • usually oestrogen dependent endometrioid adenocarcinomas
    • generally have a good prognosis.
  • type 2 tumours
    • usually present late and are more aggressive
    • carry a poor prognosis
    • not oestrogen driven
    • risk of relapse and metastasis is high
    • commonest histological types are uterine papillary serous carcinoma and clear cell carcinoma 

  • are around 9,100 new uterine cancer cases in the UK every year, that's 25 every day (2013-2015)

  • in females in the UK, uterine cancer is the 4th most common cancer, with around 9,000 new cases in 2015

  • uterine cancer accounts for 5% of all new cancer cases in females in the UK (2015). Incidence rates for uterine cancer in the UK are highest in females aged 75 to 79 (2013-2015)

  • since the early 1990s, uterine cancer incidence rates have increased by almost three-fifths (56%) in females in the UK

  • over the last decade, uterine cancer incidence rates have increased by around a fifth (21%) in females in the UK

  • most uterine cancers occur in the endometrium

  • uterine cancer incidence in England is not associated with deprivation

  • uterine cancer is as common in White, Asian and Black females

  • an estimated 70,200 women who had previously been diagnosed with uterine cancer were alive in the UK at the end of 2010

The overall prognosis is relatively good as most cases are caught early following investigation for post-menopausal bleeding. Nulliparous women and those of low parity seem to be affected most frequently



The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.